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PHeart Rhythm Disorders
Alcohol Consumption and Risk of Atrial Fibrillation
A Meta-Analysis
Satoru Kodama, MD, PHD,* Kazumi Saito, MD, PHD,* Shiro Tanaka, PHD,† Chika Horikawa, RD,*
Aki Saito, RD,* Yoriko Heianza, RD,* Yui Anasako, RD,* Yukako Nishigaki, RD,* Yoko Yachi, MS,*
Kaoruko Tada Iida, MD, PHD,* Yasuo Ohashi, PHD,‡ Nobuhiro Yamada, MD, PHD,*
Hirohito Sone, MD, PHD*
Ibaraki, Kyoto, and Tokyo, Japan
Objectives The purpose of this meta-analysis is to summarize the estimated risk of atrial fibrillation (AF) related to alcohol
consumption.
Background Results from observational studies examining the relationship between alcohol consumption and AF are inconsistent.
Methods A systematic electronic search of Medline (January 1966 to December 2009) and Embase (January 1974 to De-
cember 2009) databases was conducted for studies using key words related to alcohol and AF. Studies were
included if data on effect measures for AF associated with habitual alcohol intake were reported or could be
calculated. The effect measures for AF for the highest versus lowest alcohol intake in individual studies were
pooled with a variance-based method. Linear and spline regression analyses were conducted to quantify the re-
lationship between alcohol intake and AF risk.
Results Fourteen eligible studies were included in this meta-analysis. The pooled estimate of AF for the highest versus
the lowest alcohol intake was 1.51 (95% confidence interval: 1.31 to 1.74). A linear regression model showed
that the pooled estimate for an increment of 10 g per day alcohol intake was 1.08 (95% confidence interval:
1.05 to 1.10; R2  0.43, p  0.001). A spline regression model also indicated that the AF risk increased with
increasing levels of alcohol consumption.
Conclusions Results of this meta-analysis suggest that not consuming alcohol is most favorable in terms of AF risk
reduction. (J Am Coll Cardiol 2011;57:427–36) © 2011 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2010.08.641t
(
b
v
o
d
s
c
r
h
c
g
i
o
c
c
f
ttrial fibrillation (AF) is the most common sustained
rrhythmia, representing a growing epidemic, and is accom-
anied by serious complications. Atrial fibrillation accounts
or 45% of all embolic strokes and has a deleterious impact
n longevity, with an approximate doubling of all-cause
ortality (1). Although the etiology of AF is not fully
nderstood, many epidemiological associations with AF,
ncluding both cardiac (e.g., valvular disease, cardiomyopa-
rom the *Department of Internal Medicine, University of Tsukuba Institute of
linical Medicine, Ibaraki, Japan; †Department of Clinical Trial, Design and
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ciences, University of Tokyo, Tokyo, Japan. Drs. Sone and Kodama are recipients of
Grant-in-Aid for Scientific Research (20300227) and Postdoctoral Research
ellowship (202965), respectively, both from the Japan Society for the Promotion of
cience. This work is also financially supported by the Japan Cardiovascular Research
oundation and Ministry of Health, Labor, and Welfare, Japan. The sponsors had no
nfluence over the design and conduct of the study; collection, management, analysis,
nd interpretation of the data; or preparation, review, or approval of the manuscript.
he authors have reported that they have no relationships to disclose.f
Manuscript received May 18, 2010; revised manuscript received July 26, 2010,
ccepted August 10, 2010.hy, coronary artery disease) (2) and noncardiac conditions
e.g., aging, obesity, sleep apnea, diabetes mellitus, meta-
olic syndrome, heavy alcohol consumption) (3) have been
igorously investigated.
The association of episodic heavy alcohol use with the
nset of AF has been recognized as “holiday heart syn-
rome” for a long time (4). Recently, it has been hypothe-
ized that not only episodic but also habitual heavy alcohol
onsumption is associated with the risk of AF (5). However,
esults from epidemiological studies that aim to confirm this
ypothesis have been inconsistent, although high alcohol
onsumption has been associated with several major disease
roups such as neoplasms and cardiovascular diseases (6). It
s also important to clarify the overall impact of any degree
f alcohol intake on AF risk given that moderate alcohol
onsumption has been associated with a lower risk of
ardiovascular disease (7) or all-cause mortality (8). There-
ore, our aim of this meta-analysis of observational studies is
o review the risk of AF in relation to alcohol consumption,
ocusing on determining if there is a dose-response relation-
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Alcohol and Atrial Fibrillation January 25, 2011:427–36ship between any degree of alco-
hol consumption and the risk of
AF as well as AF risk in relation
to heavy alcohol drinking.
Methods
Search strategy. Electronic lit-
erature searches (Medline, Janu-
ary 1966 to December 2009; and
Embase, January 1974 to De-
ember 2009) to identify studies describing alcohol intake
nd AF were conducted using medical subject headings
elated to alcohol (alcohol drinking OR alcohol related
isorders OR alcoholism OR alcoholic beverage OR etha-
ol) and AF (arrhythmias OR atrial fibrillation). Reference
ists from the identified articles were manually examined for
elevant new articles. This process was repeated until no
dditional articles could be identified. No language restric-
ion was imposed.
For inclusion, a study had to fulfill the following criteria:
) have a cohort or case-control design; 2) identify AF as an
utcome variable of interest separate from other arrhyth-
ias; and 3) provide or allow calculation of the effect
easure (i.e., relative risk [RR] in a prospective study or
dds ratio [OR] in a retrospective study) with its corre-
ponding confidence interval (CI). As an exception, because
f the overlap between AF and atrial flutter, studies in
hich AF and atrial flutter were combined as a study
utcome were also included. However, when data on risk of
oth AF only and the combination of AF and atrial flutter
ere provided simultaneously in 1 study, we used data on
he risk of AF only. We excluded studies wherein alcohol
onsumption was classified as “yes” or “no” because the
egree of daily alcohol consumption could not be ascer-
ained through such a response.
ata extraction. Two of our investigators (S.K. and H.S.)
ndependently reviewed all relevant articles and identified
ligible studies. Discrepancies were resolved by group dis-
ussion. We extracted the following data from each publi-
ation: first author’s name, year of publication, geographic
egion, design of the observational study (i.e., cohort or
ase-control), selection of study population (i.e., hospital-
ased or population-based), participants’ characteristics
i.e., age [mean or range], proportion of men, and whether
articipants with heart disease that influenced AF risk were
xcluded), characteristics of outcome (i.e., onset or recur-
ence, dominantly paroxysmal atrial fibrillation [PAF] or
ominantly chronic [persistent] AF, and whether atrial
utter was included in the study outcome), methods of
ssessment of alcohol consumption (i.e., questionnaire,
nterview, or reviews of medical records and registries),
ethods for ascertainment of AF (i.e., electrocardiogram
creening, registries, or participant’s report), category of
lcohol intake, number of participants and cases, and
Abbreviations
and Acronyms
AF  atrial fibrillation
CI  confidence interval
OR  odds ratio
PAF  paroxysmal atrial
fibrillation
RR  relative risktudy-specific controlled variables. iThe effect measure in each study was extracted or, if the
ffect measure for AF was not provided, it was calculated
ased on data on the number of cases and noncases in
eferent and exposed groups. In principle, we defined the
owest alcohol intake category or no drinking as the referent
roup and the other category as the exposed group. When a
tudy classified2 alcohol intake categories, we extracted or
alculated all available effect measures for AF. If a study
rovided several effect measures, such as unadjusted and
djusted effect measures, the most completely adjusted effect
easure was used.
The effect measures were transformed to their natural
ogarithm (log OR/RR). Fundamentally, the standard error
SE) was calculated from the corresponding CI. In some
tudies (9–11), the SE corresponding to the log OR/RR
as not provided. Then we directly calculated the SE
orresponding to the log OR/RR using data on the number
f cases and noncases in the exposed and referent groups in
ach comparison as follows:
SE2
1
C1

1
N1

1
C0

1
N0
in case of log OR) (9,11) or:
SE2
1
C1

1
C1N1

1
C0

1
C0N0
in case of log RR) (10), where C1 and N1 indicate the
umber of cases and noncases in the exposed group,
espectively, and C0 and N0 indicate the number of cases
nd noncases in the referent group, respectively. If neces-
ary, the effect measure and its corresponding SE were
pproximated from figures in the manuscripts using an
mage scanner (CanoScan LiDE 500F [resolution 600 dpi],
anon, Inc., Tokyo, Japan).
To standardize alcohol intake, we used a common scale
grams per day) for ethanol consumption. When a study
sed the number of drinks per day as a unit of alcohol
ntake, the unit was transformed into grams of ethanol
ccording to the study-specific methods for estimating the
mount of ethanol per drink. If the amount of ethanol per
rink was not specified, the unit was considered equivalent
o 12 g ethanol (12).
For each study, data on the mean level of daily alcohol
ntake for each category were extracted or calculated as point
stimates of ethanol consumption. When this information
as not provided, we assigned the mid-point of the upper
nd lower boundaries in each category as the average intake.
f the highest category had an open upper boundary, mean
lcohol intake was estimated to be 1.2 times the lower
oundary (13).
ata synthesis. To summarize the association of habitual
eavy alcohol consumption with the risk of AF, the effect
easures were pooled for the highest versus lowest alcoholntake category. Based on the definition of heavy alcohol
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January 25, 2011:427–36 Alcohol and Atrial Fibrillationrinking by the National Institute on Alcohol Abuse and
lcoholism (12), we limited this analysis to studies in which
he highest alcohol intake category was defined as consump-
ion of 2 or more drinks per day for men, 1 or more drinks
er day for women, and 1.5 or more drinks per day for the
ombination of men and women. Subjects described as
alcohol abusers” and “alcoholics” were also considered to be
eavy drinkers. The pooled estimate was calculated by
veraging the log OR/RRs weighted by the inverse of
ariance based on a fixed- or random-effects model. We
sed the results from the random-effects model if between-
tudy heterogeneity, which was assessed by Q statistics and
-squared (14), was significant (15). Because daily alcohol
onsumption in heavy alcohol drinkers varied from study to
tudy, we conducted stratified analysis according to the
egree of “heavy” drinking. Analyses were also stratified by
he pre-specified study characteristics. We also conducted
eta-regression analyses to assess the influence of study
haracteristics on study results.
The possibility of publication bias was assessed primarily
y visual inspection of a funnel plot in which the effect
easure in the individual study was plotted against its
orresponding SE. The funnel plot is expected to be
ymmetrical with respect to the overall estimate if publica-
ion bias is absent. We secondarily assessed the possibility of
ublication bias by 2 formal tests: the Begg’s adjusted rank
orrelation test (16) and the Egger’s regression asymmetry
est (17). If publication bias was statistically suspected, we
lso followed the Duval and Tweedie “trim and fill” proce-
ure (18) for further estimation of the possible effect of the
ublication bias. This method considers the possibility of
ypothetical unpublished studies that would have allowed a
unnel plot to be symmetrical and recalculates a pooled
1754 Citations Found in 
Databases Using Search 
Terms
591 MEDLINE
1163 EMBASE
1
a
20 Articles 
Obtained from 
Manual Searches
81 Potentially Relevant Studies 
for More Detailed Evaluations
87 Articles 
25 Revie
13 Case s
3   Cross-
10 Did no
5 Assessed
determine w
9 Did no
intake
19 Did n
(OR/RR) of
1 Standar
1 Data up
1 Same co
14 Articles Included 
in Our Analysis Figure 1 Study Flow Chart of Meta-Analysisstimate after imputation of the effect measures of the
ypothetical studies as though they actually existed.
We primarily used weighted, least-squared regression
odels (19) to explore the dose-response relationship be-
ween alcohol intake and the risk of AF by regressing the
og OR/RR of AF on the alcohol dose. To further investi-
ate the shape of the relationship between the level of
lcohol consumption and the risk of AF, we used restricted
ubic splines with knots at the 25th, 50th, and 75th centiles
f the distribution of alcohol consumption. These analyses
ere limited to data from studies with a referent category
hose mean alcohol consumption was reported or estimated
o be less than 1 drink per day, so that overlapping of
lcohol intake of exposed and referent groups could be
voided as much as possible. Two-sided p values of  0.05
ere considered statistically significant except for tests of
ublication bias for which the recommended level is p value
0.10 (20). Data were analyzed using STATA software
ersion 10 (STATA Corp., College Station, Texas).
esults
tudy characteristics. Figure 1 shows details of the liter-
ture search. Our electronic literature search resulted in
etrieval of 1,754 citations (591 from Medline and 1,163
rom Embase). Of these, 1,673 citations were excluded
fter the first screening. Eighty-one papers as well as 20
dditional papers identified by manual search were left
or full-text review. After this review, of the 101 papers,
7 were excluded for the reasons shown in Figure 1.
inally, 14 studies (9–11,21–31), which comprised 130,820
articipants and 7,558 cases, were included in this
eta-analysis.
xcluded Based on Title 
stract
ded for the Following Reasons:
cles
al studies
s alcohol intake
ol intake as Yes or No (i.e., impossible to 
r alcohol intake is high or moderate.)
tigate chronic but acute effect of alcohol 
vide data on odds ratios or relative risks 
l fibrillation for high vs. low/non alcohol intake
r of OR/RR could not be estimated
 by more recent studies
s one of the included studies   673 E
nd Ab
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Alcohol and Atrial Fibrillation January 25, 2011:427–36Characteristics of the 14 included studies are shown in
able 1. Nine studies used a cohort design, 4 studies used
case-control design, and 1 study reported data from
oth case-control and cohort designs. All studies were
onducted in Western countries (7 in Europe and 7 in
orth America).
For assessing daily alcohol consumption, only 4 of the 14
tudies (25,26,29,31) validated methods to assess alcohol
ntake. All effect measures were controlled for age and sex,
nd most of the included reports (10 studies) made adjust-
ents for heart disease, which potentially elevates the risk of
haracteristics of Studies Included in the Meta-AnalysisTable 1 Characteristics of Studies Included in the Meta-Analys
Authors (Ref. #)
Year of
Publication Design
Rich et al. (9) 1985 Case-con
Cohen et al. (10) 1988 Cohort
Krahn et al. (21) 1995 Cohort
Wilhelmsen et al. (22) 2001 Cohort
Ruigomez et al. (23) 2002 Case-con
Djousse et al. (24) Men 2004 Cohort
Women
Frost and Vestergaard (25) Men 2004 Cohort
Women
Mattioli et al. (11) 2005 Case-con
Mukamal et al. (26) Men 2005 Cohort
Women
Ruigomez et al. (27) PAF 2005 Case-con
Chronic Cohort
Planas et al. (28) 2006 Cohort
Mukamal et al. (29) 2007 Cohort
Conen et al. (30) 2008 Cohort
Marcus et al. (31) 2008 Case-con
Were Patients
With Heart
Disease
Excluded?
PAF Dominant
or Chronic-AF
Dominant
Was M
Distin
From
AF D
Rich et al. (9) Yes PAF
Cohen et al. (10) No Chronic
Krahn et al. (21) No Chronic
Wilhelmsen et al. (22) No Chronic
Ruigomez et al. (23) No Chronic
Djousse et al. (24) No Chronic
Frost and Vestergaard (25) Yes Chronic
Mattioli et al. (11) Yes PAF
Mukamal et al. (26) Yes Chronic
Ruigomez et al. (27) PAF No PAF
Chronic No Chronic
Planas et al. (28) Yes PAF
Mukamal et al. (29) No Chronic
Conen et al. (30) Yes Chronic
Marcus et al. (31) No PAFF, or excluded participants with heart disease. Only 3 ptudies (10,29,31) considered racial differences among the
articipants.
isk of AF through heavy alcohol consumption. The
owest amount of alcohol consumed in the highest category
n each study ranged from 1.5 to 6 drinks per day.
onsequently, in all 14 studies, the criteria for heavy alcohol
rinking as previously defined were met (12). Three studies
eported separate results according to sex. One study ana-
yzed 2 populations separately according to age (60 years
r 60 years), and 1 study indicated 2 risk measures (1 for
AF and another for the progression from an AF episode to
Selection of
Population Country
Age (yrs),
Range (Mean)
%
Men
Hospital-based U.S. 18–70 76
Population-based U.S. NA NA
Population-based Canada 18–62 (31) 100
Population-based Sweden 47–55 100
Hospital-based Sweden 40–89 46
Population-based U.S. 28–62 100
0
Hospital-based Denmark 50–64 100
0
Population-based Italy 54 74
Population-based U.S. 26–75 (51) 100
26–73 (52) 0
Hospital-based Sweden 40–89 47
Hospital-based 40–89 49
Hospital-based Spain 53 64
Population-based U.S. 65 42
Population-based Switzerland 45 (53) 0
Both U.S. 53 75
d to
PAF
nic
ed?
Onset or
Recurrent AF
Was Atrial
Flutter Among
AF Events
Included?
Method of
Ascertaining AF
Method for
Assessment of
Exposure
Onset No Medical records Medical records
Onset No Medical records Questionnaires
Onset No ECG screening or
physicians’ report
Medical records
Onset No Registries Questionnaires
Onset No Registries Medical records
Onset Yes ECG screening Questionnaires
Onset Yes Registries Questionnaires
Onset No Medical records Questionnaires
Onset Yes ECG screening,
medical records,
Registries
Interviews
Onset No Registries Medical records
Recurrent No Registries
Recurrent No ECG screening Medical records
Onset Yes ECG screening,
medical records,
Registries
Questionnaires
Onset No Participants’ reports Questionnaires
Onset No Medical records Interviews
Continued on next pageis
trol
trol
trol
trol
trol
etho
guish
Chro
escrib
Yes
No
No
No
Yes
No
No
Yes
No
Yes
Yes
No
No
Noermanent AF). Finally, 19 effect measures were analyzed to
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January 25, 2011:427–36 Alcohol and Atrial Fibrillationummarize the risk of AF in relation to heavy alcohol
ntake. The pooled estimate of OR/RR for the highest
ategory of alcohol consumption compared with the lowest
ategory in individual studies was 1.51 (95% CI: 1.31 to
.74) (Fig. 2).
There was significant between-study heterogeneity in the
ffect measures (Q-squared, 33.2; I-squared, 45.8%; p 
.02). Table 2 shows results of stratified and meta-
egression analyses across a number of key study character-
ontinuedTable 1 Continued
Category of Alcohol Inta
Rich et al. (9) 70 ml/day or not
Cohen et al. (10) 6 or more drinks/day or 1
Krahn et al. (21) Self- and physician-reported a
Wilhelmsen et al. (22) Alcohol abuse or not
Ruigomez et al. (23) None, 1–5, 6–15, 16–42, 4
Djousse et al. (24) Men None, 0.1–12, 12.1–24, 24.1
Women
Frost and Vestergaard (25) Men Quintile (4.1, 12.1, 20.0, 36.
Women Quintile (1.1, 4.6, 9.4, 15.6, 3
Mattioli et al. (11) 0, 1–20, 21–50, 50 ml/day
Mukamal et al. (26) Men 1, 1–6, 7–13, 14–20, 21–2
(1 drink  12 g)
Women 1, 1–6, 7–13, 14–20, 20
Ruigomez et al. (27) PAF None, 1–7, 8–21, 21 U/week
Chronic
Planas et al. (28) 40 g/day or not (men);
20 g/day or not (women)
Mukamal et al. (29) None, former, 1, 1–6, 7–13
Drinks/week (1 drink  13.3
Conen et al. (30) None, 1, 1–2, 2 drinks/da
Marcus et al. (31) 1.5 drinks/day or not
Age/Sex Smoking
Study BMI
or WC
Rich et al. (9) ✓
Cohen et al. (10) ✓ ✓
Krahn et al. (21) ✓
Wilhelmsen et al. (22) ✓
Ruigomez et al. (23) ✓
Djousse et al. (24) ✓
Frost and Vestergaard (25) ✓ ✓ ✓
Mattioli et al. (11) ✓
Mukamal et al. (26) ✓ ✓ ✓
Ruigomez et al. (27) PAF ✓
Chronic
Planas et al. (28) ✓
Mukamal et al. (29) ✓ ✓
Conen et al. (30) ✓ ✓ ✓
Marcus et al. (31) ✓ ✓
Duration is the duration between the time point of alcohol consumption and subsequent observ
isease.
AF  atrial fibrillation; BMI  body mass index; ECG  electrocardiogram; HT  hypertension
ircumference.stics to explore causes of the study heterogeneity. On the shole, a positive association between AF risk and heavy
lcohol consumption was consistently found in all stratified
nalyses.
In the stratified analysis by mean alcohol intake in the
ighest intake group, the pooled estimates of AF for 4
rinks per day, or 48 g per day, and 4 drinks per day was
.32 (95% CI: 1.15 to 1.50) and 1.74 (95% CI: 1.35 to
.24), respectively. However, the difference was not signif-
cant (p  0.17). When analyses were limited to the 6
hanol Consumption)
No. of
Cases
No. of
Participants
Duration
(yrs)*
58 116 —
ay 28 3,966 —
lism or not 299 3,983 44
754 7,495 25.2
eek (1 U  10 ml) 1,035 6,035 —
36 g/day 544 2,921 24
511 2,806
g/day) 374 22,528 5.7
/day) 182 25,421 5.8
116 232 —
34, 34 drinks/week 548 7,588 16.3
/week (1 drink  12 g) 523 8,827 18.8
10 ml) 525 5,525 —
70 418 2.7
32 115 2.5
1,232 5,609 9.1
rink  15 g) 653 34,175 12.4
74 260 —
founders
P or HT
Heart
Disease† Other Control Variables
Total No. of Control
Variables
✓ 2
Race 3
1
1
✓ 2
✓ ✓ 3
✓ ✓ 5
✓ 2
✓ ✓ Education, income, diabetes,
physical activity,
10
respiratory function
1
✓ ✓ 3
✓ ✓ Race, income, diabetes, use of
psychoactive
8
medication
✓ ✓ Diabetes 6
✓ ✓ Race 5
Cardiac function (e.g.. left ventricular end-systolic volume, left atrial size) was involved in heart
not available; PAF  paroxysmal atrial fibrillation; SBP  systolic blood pressure; WC  waistke (Et
drink/d
lcoho
2 U/w
–36, 
1, 68.7
8.8 g
7, 28–
drinks
(1 U 
, 13
g)
y (1 d
Con
SB
ation. †tudies that regarded nondrinkers as the referent group, the
p
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Alcohol and Atrial Fibrillation January 25, 2011:427–36ooled estimate for the highest category was 1.36 (95% CI:
.18 to 1.57).
Stratified analysis by geographic region, participants’ sex,
r whether persons with heart disease were included did not
how any significant difference in pooled estimates between
trata. Using a case-control design seemed to produce a
ubstantially larger AF risk (pooled estimates 1.98 [95% CI:
.49 to 1.63]) compared with the use of other designs (pooled
stimate 1.34 [95% CI: 1.22 to 1.47]). However, these differ-
nces were not borderline significant (p  0.06). Selecting
ospital-based participants produced a borderline significantly
arger pooled estimate in comparison with population-based
articipants (pooled estimate 1.75 [95% CI: 1.45 to 2.11] vs.
.30 [95% CI: 1.18 to 1.44]; p  0.049).
Strong associations were observed when the type of AF end
oint in the study was PAF-dominant (pooled estimate 1.92
95% CI: 1.44 to 2.56]) or AF recurrence (pooled estimate
.37 [95% CI: 1.44 to 3.90]) whereas a significantly weaker
ssociation was observed in studies that included atrial flutter as
Figure 2 OR/RR and 95% CI of AF by Alcohol Intake Group
Odds ratio (OR) or relative risk (RR) and 95% confidence interval (CI) of atrial fibrill
Size of squares reflects the statistical weight of each study. Overall estimate is instudy end point (pooled estimate 1.25 [95% CI: 1.10 to p.43]) than in those that did not (pooled estimate 1.83 [95%
I: 1.45 to 2.30]; p  0.02).
The method for ascertainment of AF did not significantly
ffect the magnitude of the association between high alcohol
onsumption and AF risk. However, a significantly stronger
ssociation was observed when reviewed data on alcohol
ntake were based on medical records or registries (pooled
stimate 2.17 [95% CI: 1.74 to 2.70]) compared with other
ethods of determining alcohol consumption, such as
uestionnaires or interviews (pooled estimate 1.28 [95% CI:
.16 to 1.41]; p  0.001). The influence of study adjust-
ents for possible confounders was not significant, al-
hough AF effect measures were attenuated with adjustment
or hypertension or blood pressure (pooled estimate 1.33
95% CI: 1.17 to 1.50]).
Publication bias was visually suggested by the asymmet-
ical funnel plot of the reported results (Fig. 3), which was
lso statistically supported by Egger’s test (p 0.03) but not
egg’s test (p  0.31). We attempted to adjust for this
AF) for highest versus lowest alcohol intake groups.
by unshaded diamond. PAF  paroxysmal atrial fibrillation.ation (
dicatedublication bias using the trim and fill method (18). After 4
S*
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January 25, 2011:427–36 Alcohol and Atrial Fibrillationtratified Analyses of Pooled Relative Risk of Atrial Fibrillation for Highest Alcohol Intake Versus Lowest Alcohol IntakeTable 2 Stratified Analyses of Pooled Relative Risk of Atrial Fibrillation for Highest Alcohol Intake Versus Lowest Alcohol Intake
Variable
No. of
Data Units
Risk Estimates
(95% CI) Q Statistics I-Squared
p Value of
Heterogeneity
Meta-
Regression*
Mean estimated alcohol intake of exposed group
4 drinks (48 g) per day 11 1.32 (1.15–1.50) 13.1 23.6% 0.22 Referent
4 drinks (48 g) per day or alcohol abuser 8 1.74 (1.35–2.24) 18.8 62.8% 0.009 0.16
Drinking status of referent group
Nondrinkers 8 1.36 (1.18–1.57) 12.6 44.6% 0.08 Referent
Light drinkers 11 1.56 (1.27–1.91) 20.5 51.1% 0.03 0.73
Design
Cohort 13 1.34 (1.22–1.47) 20.4 41.1% 0.06 Referent
Case-control 6 1.98 (1.49–2.63) 6.5 22.5% 0.26 0.06
Selection of study population
Population-based 10 1.30 (1.18–1.44) 14.3 37.0% 0.11 Referent
Hospital-based 7 1.75 (1.45–2.11) 10.8 44.2% 0.10 0.06
Both population- and hospital-based 2 1.28 (0.49–3.39) 1.1 6.7% 0.30 0.88
Geographic region
North America 10 1.50 (1.19–1.90) 19.5 53.7% 0.02 Referent
Europe 9 1.40 (1.25–1.58) 13.7 41.8% 0.09 0.76
Sex
Men 4 1.32 (1.06–1.64) 2.3 — 0.51 Referent
Women 5 1.37 (1.21–1.55) 7.3 45.0% 0.12 0.47
Men/women 10 1.85 (1.33–2.56) 22.8 60.5% 0.007 0.32
Excluding participants with heart disease
No 11 1.50 (1.24–1.82) 20.5 51.3% 0.03 Referent
Yes 8 1.53 (1.31–1.80) 10.6 34.1% 0.16 0.79
Was atrial flutter included as AF outcome?
No 12 1.83 (1.45–2.30) 23.8 53.9% 0.01 Referent
Yes 7 1.25 (1.10–1.43) 5.1 — 0.52 0.02
Type of AF outcome
Chronic AF dominant 14 1.43 (1.24–1.66) 22.0 45.4% 0.04 Referent
PAF dominant 6 1.92 (1.44–2.56) 6.0 17.2% 0.30 0.11
Was AF outcome the first episode or recurrence?
First episode 17 1.46 (1.27–1.69) 28.5 43.8% 0.03 Referent
Recurrence 2 2.37 (1.44–3.90) 0.3 — 0.59 0.10
Methods for assessment of alcohol intake
Questionnaires 9 1.26 (1.13–1.40) 7.4 — 0.50 Referent
Interviews 4 1.41 (1.07–1.85) 3.0 — 0.39 0.45
Historical data reviews 6 2.17 (1.74–2.70) 3.7 — 0.60 0.001
Methods for ascertainment of AF
ECG screening 3 1.47 (1.12–1.95) 2.5 20.0% 0.29 Referent
Medical records 5 2.14 (1.38–3.31) 5.5 27.6% 0.24 0.28
Registries 6 1.35 (1.19–1.54) 10.2 51.1% 0.07 1.00
Others† 5 1.43 (1.11–1.85) 10.8 62.9% 0.03 0.83
Study adjustment
Smoking
No 13 1.58 (1.29–1.95) 28.0 57.2% 0.005 Referent
Yes 6 1.47 (1.24–1.73) 4.6 — 0.46 0.68
Obesity (BMI or waist circumference)
No 11 1.76 (1.40–2.21) 23.3 57.1% 0.01 Referent
Yes 8 1.29 (1.13–1.48) 7.9 10.9% 0.34 0.07
SBP or HT
No 9 1.93 (1.40–2.64) 20.8 66.3% 0.004 Referent
Yes 10 1.33 (1.17–1.50) 11.0 9.4% 0.35 0.06
Heart disease
No 5 1.74 (1.24–2.43) 11.3 64.4% 0.02 Referent
Yes 14 1.39 (1.24–1.56) 22.0 40.8% 0.06 0.44Represents test for significance of the study modification across strata. †Participants’ report or using combination of registry with electrocardiographic screening.
CI  confidence interval; other abbreviations as in Table 1.
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Alcohol and Atrial Fibrillation January 25, 2011:427–36egative unpublished results were incorporated to produce a
ypothetically symmetrical funnel plot, the pooled estimate
f AF for heavy alcohol consumption was modestly atten-
ated to be 1.39 (95% CI: 1.19 to 1.62) but remained
tatistically significant (p  0.001).
ose-response relationship between alcohol intake and
F risk. Nine studies (10,11,23–27,29,30) involving
26,051 participants and 6,341 cases were eligible for
nalysis of the dose-response relationship between different
ategories of alcohol intake and AF risk. The alcohol dose in
hese studies ranged from 4.0 to 86.4 g per day. Figure 4
llustrates the linear and spline regression curves for AF risk
elated to daily alcohol intake. The linear dose-response
urve showed a significant relationship between alcohol
ntake and AF risk (R2  0.43, p  0.001). The coefficient
or the linear term was 7.4  1.3  103, meaning that the
ncremental increase in relative risk of AF per 10 g alcohol
onsumption per day was e107.41.310
3
 1.08 (95% CI:
.05 to 1.10). Also, in the spline regression model, AF risk
ignificantly increased with larger daily alcohol consumption
evels (R2  0.44, p  0.001). However, the fit of this
odel was not significantly different from that of the linear
egression model (p  0.77).
iscussion
ur study is the first to systematically review the literature
n the association between alcohol consumption and the
isk of AF. In this review, high alcohol intake was shown to
e associated with a significant elevation in AF risk, both by
verall analysis and across a number of stratified analyses
ased on key characteristics of study methods, although
here was substantial study heterogeneity in the magnitude
f AF risk, partly due to variability in study design and
Figure 3 Funnel Plot of High Alcohol Consumption and AF
Funnel plot of high alcohol consumption and atrial fibrillation (AF) risk before
and after adjustment for publication bias using trim and fill procedures. Hypo-
thetical dummy studies indicated by circles within squares are added to the
genuine studies indicated by circles. OR  odds ratio; RR  relative risk.ethodology. Even though, in principle, observationaltudies do not allow for proof of causality, there are several
heoretically plausible speculations for the cause-effect rela-
ionship between high alcohol intake and the development
f AF.
One speculation is based on biological findings that
uggest a harmful effect of high alcohol intake on mainte-
ance of normal heart rhythm, including the achievement of
hyperadrenergic state (32), impairment of vagal tone (33),
irect effect on myocardial structure (34), and various
lectrophysiological changes in atrial cells (e.g., increase in
ntra-atrial conduction time represented by a length of the
-wave, reduction in the refractory period, negative inotro-
ic effect through calcium-channel inhibition in ventricular
ells) (31,35,36).
Another speculation is based on reports suggesting that
he development of chronic heart failure accompanied by
ong-term excessive alcohol consumption may result in
levated AF risk (2). Particularly, dilated cardiomyopathy is
ypical of alcohol abusers with chronic heart failure. The
verage total lifetime alcohol consumption was reported to
e significantly greater in patients with dilated cardiomyop-
thy than in a population-based control group (37). More-
ver, alcoholics were found to have progressive dilated
ardiomyopathy in proportion to the duration of heavy
rinking even before the clinical appearance of chronic heart
ailure (38).
It remains to be established whether the dose-response
elationship between daily alcohol consumption and AF risk
s interpreted as linear or not (e.g., J-shaped curve, threshold
urve). While we identified a linear association of daily
lcohol consumption with the risk of AF, a J-shaped
elation or threshold value was not observed from the
Figure 4 Regression of Natural Log OR/RR for
Atrial Fibrillation on Daily Alcohol Consumption
The solid curve and its accompanying area indicate the log odds ratio or rela-
tive risk (OR/RR) and its corresponding 95% confidence interval based on a
restricted cubic spline regression model with knots at 8, 22.5, and 33.1 g/day
of alcohol consumption. This model did not significantly improve the fit com-
pared with the linear regression model expressed by the dotted line. The area
of each data point is proportional to its statistical weight.
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January 25, 2011:427–36 Alcohol and Atrial Fibrillationurrent spline regression curve. These regression analyses
uggest no evidence that moderate alcohol consumption is
eneficial in ameliorating the risk of AF, unlike that of
ardiovascular disease (7). If anything, moderate alcohol
rinkers may have a greater risk of AF than nondrinkers,
lthough the AF risk is not as large as that for heavy
rinkers.
tudy limitations. First, the definition of heavy drinking is
eterogeneous across studies. Second, the majority of the
ncluded studies did not state whether the method used for
ssessment of alcohol intake was validated. Third, few
tudies considered racial differences among participants.
ifferences in ethnicity or proportion of whites and non-
hites among different studies might have affected AF risk
stimates. Fourth, asymptomatic PAF could have been
issed in any of these studies. Given that heavy alcohol
rinkers are likely to have experienced PAF, the risk of AF
n relation to high alcohol intake would be underestimated
n any of the examined studies. Fifth, no studies have
nvestigated the effect of different types of alcoholic bever-
ges on AF risk, although it has been reported that wine has
better effect on cardiovascular disease (39). Sixth, it could
ot be ruled out whether a particular drinking pattern, such
s whether alcohol was consumed with a specific food or at
eals, could have contributed to the AF risk irrespective of
lcohol dosage. For example, alcohol is usually consumed
uring meals, as in Mediterranean countries (39), which
ight explain a beneficial effect.
A meta-analysis cannot completely solve problems with
onfounders that vary from study to study. Lack of adjust-
ent for possible confounders could also produce a super-
cially strong association between high alcohol consump-
ion and AF risk. For example, a weaker association
etween high alcohol consumption and AF risk was ob-
erved when studies included blood pressure values or the
resence of hypertension among study confounders. In fact,
ypertension was reported to be an independent risk factor
or AF (2), and the risk of hypertension increases linearly
ith alcohol consumption (40). Possibly, the AF risk
ssociated with high alcohol consumption is partly ex-
lained by an alcohol-related development of hypertension.
n addition, other factors that could not be specified by this
eta-analysis or were not specified in the individual in-
luded studies might contribute to residual confounding
e.g., objective sleep apnea [41], diabetes mellitus [42]).
Lastly, results that indicated risk of AF could be biased by
tudy design and other methodological features. For exam-
le, larger AF risk estimates were observed in studies having
case-control design compared with studies having a cohort
esign or in hospital-based studies compared with
opulation-based studies. The AF risk could have been
verestimated by exaggeration of alcohol intake in patients
ith AF in studies with a case-control design (i.e., recall
ias) or an unavoidable reduction in alcohol intake as a
esult of a control subject having an illness in a hospital-
ased setting (i.e., selection bias). However, underestima-
1ion of AF risk is possible if patients did not truthfully
eport the full extent of alcohol intake when completing
uestionnaires.
onclusions
abitual heavy alcohol drinking is associated with an
ncreased risk of AF, although several study limitations exist
nd must be recognized. The relationship between daily
lcohol consumption and the risk of AF was explained by a
inear dose-response model, suggesting that not consuming
lcohol at all is the most favorable behavior for avoiding AF
ather than moderate alcohol consumption. Further inves-
igation is needed to establish the extent to which this
ssociation is explained by a causal relationship.
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